Peh C A, Horowitz M, Wishart J M, Need A G, Morris H A, Nordin B E
Department of Medicine, Royal Adelaide Hospital, Australia.
J Am Geriatr Soc. 1993 May;41(5):513-6. doi: 10.1111/j.1532-5415.1993.tb01887.x.
To evaluate the effects of short-term administration of chlorothiazide on fasting urinary hydroxyproline, an index of bone resorption, and other bone-related biochemical parameters in normal post-menopausal women.
Subjects served as their own control before and after chlorothiazide treatment.
Subjects were recruited by advertisement.
Thirteen healthy post-menopausal women with a mean age of 65 years.
Each subject was given chlorothiazide 500 mg bd po for 7 days. Fasting blood and urine samples were obtained immediately before the commencement of chlorothiazide (day 1) and 2 and 7 days after starting chlorothiazide.
Chlorothiazide decreased the urinary calcium/creatinine (mean value day 1, 0.267; day 2, 0.143; day 7, 0.135; P < 0.001) and hydroxyproline/creatinine (day 1, 0.0192; day 2, 0.0145; day 7, 0.0139; P < 0.02) molar ratios.
Chlorothiazide decreases fasting urinary hydroxyproline, a marker of bone resorption in post-menopausal women. This observation supports a potential role for thiazide diuretics in the prevention of osteoporosis. The observed fall in urinary hydroxyproline is of the same order as that seen after treatment with estrogen or calcium supplements.
Zotero 插件